Objective. The purpose of this study was to determine the utility of DNA fl
ow cytometry as a prognostic indicator for risk of recurrence and overall s
urvival in patients with early stage adenocarcinomas of the uterine cervix.
Methods. DNA how cytometry was performed to determine ploidy, DNA index, an
d proliferative index in 66 women with stages IB and IIA pure mucinous aden
ocarcinomas of the cervix treated by primary surgical therapy with radical
hysterectomy and pelvic lymphadenectomy. Fifty-seven of 66 (86.3%) tissue s
amples were analyzable. Three sections were obtained from paraffin-embedded
tissue blocks containing primary tumor. Flow-cytometric results, along wit
h other known prognostic variables for risk for recurrent disease and survi
val, were analyzed using Cox regression proportional hazards model, and sur
vival curves were generated by the Kaplan-Meier method.
Results. Of 57 interpretable samples, DNA ploidy patterns were 18 (27%) dip
loid, 8 (12%) tetraploid, and 31 (47%) aneuploid, Thirteen of 66 patients (
20%) experienced recurrence with a median time to recurrence of 1.6 years,
No significant correlation was noted between DNA ploidy and risk of recurre
nce (P = 0.429). Multivariate analysis confirmed that positive metastatic l
ymph nodes were associated with risk of recurrence (P < 0.001), In node-neg
ative patients, a high proliferative index (S% + G(2)M% > 20%), measured as
a continuous variable, was the only significant factor for tumor recurrenc
e (P = 0.002).
Conclusion. DNA ploidy does not predict a patient's risk for tumor recurren
ce; however, a high proliferative index value warrants further investigatio
n as a potential prognostic indicator for risk of recurrent disease in pati
ents with adenocarcinoma of the uterine cervix. (C) 1999 Academic Press.